0
Abstract: Poster Presentations |

PLASMA LEVELS OF B-TYPE NATRIURETIC PEPTIDE IN ACUTE CORONARY SYNDROME: PROGNOSTIC SIGNIFICANCE AND THERAPEUTIC IMPLICATIONS FREE TO VIEW

Waqas Ahmed, MD; Saman Zafar, MBBS, MD; Martin A. Alpert, MD*
Author and Funding Information

St. John’s Mercy Medical Center, Saint Louis, MO



Chest. 2006;130(4_MeetingAbstracts):191S-d-192S. doi:10.1378/chest.130.4_MeetingAbstracts.191S-d
Text Size: A A A
Published online

Abstract

PURPOSE: The purpose of this study was to assess the frequency of new heart failure, recurrent myocardial infarction (MI) or ischemia and all cause mortality 1 month following acute coronary syndrome (ACS) in patients with normal and elevated plasma B-type natriuretic peptide levels (pBNP) and to determine the effects of myocardial revascularization in such patients.

METHODS: ACS (unstable angina pectoris, non-ST segment elevation MI or ST segment elevation MI) were defined in accordance with standard guidelines. Normal and elevated pBNP were defined as ≤ 80 pg/ml and > 80 pg/ml respectively.

RESULTS: One hundred and forty six patients qualified for the study; 62 with normal and 84 with elevated pBNP. At 1 month new heart failure had occurred in 1 patient with normal pBNP (2%) and in 26 patients with elevated pBNP (31%, p<0.00001). At 1 month all cause mortality had occurred in no patients with normal pBNP and in 8 with elevated pBNP (10%, p<0.015). In subjects with normal pBNP, myocardial revascularization (percutaneous coronary intervention or coronary artery bypass surgery) did not affect the frequency of new heart failure, recurrent MI or ischemia or all cause mortality in patients with normal pBNP. In those with elevated pBNP, new heart failure occurred 19 of 41 unrevascularized patients and in 7 of 39 revascularized patients (p<0.01). All cause mortality occurred in 7 of 41 unrevascularized patients and in 1 of 39 revascularized patients (p<0.05).

CONCLUSION: The presence of elevated pBNP after admission for ACS was associated with a higher frequency of new heart failure and all cause mortality at 1 month. Myocardial revascularization produced a significant reduction in these endpoints in patients with elevated pBNP, but not in those with normal pBNP.

CLINICAL IMPLICATIONS: Elevated pBNP serves as a marker of increased morbidity and mortality in ACS patients and represents a subgroup with a superior response to myocardial revascularization.

DISCLOSURE: Martin Alpert, None.

Wednesday, October 25, 2006

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543